Call for Mandatory Reporting of Serious Adverse Events in Aesthetic Medicine: “You Can't Manage What You Don't Measure”

Abstract

Get full access to this article

View all access options for this article.

References

Enright

Sampalis

Cotofana

, et al. A systematic review of methods for the prevention, treatment and management of adverse events following the use of aesthetic soft tissue fillers: a call to action. Clin Exp Dermatol Ther. 2021;6: 172. doi:https://doi.org/10.29011/2575-8268.100172

Signorini

Liew

Sundaram

, et al. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016;137(6):961e-971e. doi:https://doi.org/10.1097/PRS.0000000000002184

Goodman

Liew

Callan

Hart

. Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020;61(3):217-225. https://doi.org/10.1111/ajd.13273

American Society of Plastic Surgeons. Accessed November 06, 2023. https://www.plasticsurgery.org/documents/News/Statistics/2022/plastic-surgery-statistics-report-2022.pdf.

Enright

Sampalis

Nikolis

. Adverse reactions associated with the esthetic use of soft tissue fillers and neurotoxins: a 53-year retrospective analysis of MedEffect^TM, Health Canada’s reporting database. J Dermatol Treatment. 2021;32(5):538-543. doi:https://doi.org/10.1080/09546634.2019.1682501

Enright

Andreas

Sampalis

. Global Registry of Adverse Clinical Events (GRACE©): a prospective, multicenter, observational cohort evaluating complications associated with aesthetic injectables. J Cutan Med Surg. 2024. In press.